Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Azam

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophagesXiyuan Bai, Soo-Hyun Kim, Tania Azam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2015
IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted ActivationPeleg Rider, Yaron Carmi, Rami Yossef, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activityPhilip Bufler, Tania Azam, Fabia Gamboni-Robertson, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
OLT1177 (Dapansutrile) inhibits Gasdermin D-dependent IL-1β Release and Pyroptotic Cell Death in Bone Marrow-derived MacrophagesKarl A Pankratz, Masoom Raza, Jarren Ypil, et al.
Frontiers in Immunology|December 7, 2013
The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of CytokinesBusun Kim, Youngmin Lee, Eunsom Kim, et al.
The Journal of Biological Chemistry|January 16, 2002
Identification of amino acid residues critical for biological activity in human interleukin-18Soo-Hyun Kim, Tania Azam, Daniela Novick, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationIsao Tawara, Yaping Sun, Eli C Lewis, et al.
Immune Network|May 16, 2019
Structural Characteristics of Seven IL-32 VariantsDong Hyun Sohn, Tam T Nguyen, Sinae Kim, et al.
Journal of Microbiology and Biotechnology|December 21, 2007
Individual LPS responsiveness depends on the variation of toll-like receptor (TLR) expression levelJun Jaekal, Edward Abraham, Tania Azam, et al.
BMB Reports|November 20, 2008
Proteinase 3-processed form of the recombinant IL-32 separate domainSunjong Kim, Siyoung Lee, Erk Her, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophagesXiyuan Bai, Soo-Hyun Kim, Tania Azam, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2015
IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted ActivationPeleg Rider, Yaron Carmi, Rami Yossef, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activityPhilip Bufler, Tania Azam, Fabia Gamboni-Robertson, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
OLT1177 (Dapansutrile) inhibits Gasdermin D-dependent IL-1β Release and Pyroptotic Cell Death in Bone Marrow-derived MacrophagesKarl A Pankratz, Masoom Raza, Jarren Ypil, et al.
Frontiers in Immunology|December 7, 2013
The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of CytokinesBusun Kim, Youngmin Lee, Eunsom Kim, et al.
The Journal of Biological Chemistry|January 16, 2002
Identification of amino acid residues critical for biological activity in human interleukin-18Soo-Hyun Kim, Tania Azam, Daniela Novick, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantationIsao Tawara, Yaping Sun, Eli C Lewis, et al.
Immune Network|May 16, 2019
Structural Characteristics of Seven IL-32 VariantsDong Hyun Sohn, Tam T Nguyen, Sinae Kim, et al.
Journal of Microbiology and Biotechnology|December 21, 2007
Individual LPS responsiveness depends on the variation of toll-like receptor (TLR) expression levelJun Jaekal, Edward Abraham, Tania Azam, et al.
BMB Reports|November 20, 2008
Proteinase 3-processed form of the recombinant IL-32 separate domainSunjong Kim, Siyoung Lee, Erk Her, et al.
Pageof 6